Skip to main content
Fig. 2 | BMC Immunology

Fig. 2

From: The correlation of EZH2 expression with the progression and prognosis of hepatocellular carcinoma

Fig. 2

Comparison of EZH2 expression within diverse cancers (A–F) by K–M survival curves based on GEPIA2 database as well as K–M Plot (G–J). A Survival heatmap showing EZH2 within 33 cancers obtained from the TCGA database. The rectangular box indicates the significance of prognostic analyses, and the blue and red squares indicate low and high expression, respectively. DFS and OS curves for B ACC (n = 38), C LGG (n = 257), and D LIHC (n = 180); DFS curves for E KICH (n = 32); and OS curves for F KIRC (n = 258). OS and PFS survival curves in G LIHC (n = 370, n = 316), H LUAD (n = 504, n = 300), I PAAD (n = 177, n = 69), and J KIRP (n = 287, n = 183). OS-overall survival, RFS-relapse-free survival, DFS-disease-free survival, and PFS-progression-free survival

Back to article page